Kalita J, Misra U K, Ranjan P, Pradhan P K, Das B K
Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareily Road, Lucknow 226014, India.
J Neurol Sci. 2004 Sep 15;224(1-2):19-22. doi: 10.1016/j.jns.2004.05.019.
To evaluate the regional cerebral blood flow (rCBF) changes following IV mannitol bolus in patients with intracerebral hemorrhage (ICH).
In a hospital based randomized placebo controlled study, 21 CT proven ICH patients with Glasgow coma scale (GCS) score of 5 or more were subjected to clinical evaluation including GCS and Canadian Neurological stroke (CNS) scale. Cranial SPECT study was undertaken before and 60 min after 20% mannitol 100 ml IV in 20 min or sham infusion. The SPECT images were semi-quantitatively analyzed and asymmetry index of basal ganglia, frontal, parietal and occipital regions were calculated.
There were 12 patients in mannitol and nine in control group who were evenly matched for age, mean arterial blood pressure, GCS score and size of hematoma. Only one patient died in mannitol group. Following mannitol, GCS score improved in six, worsened in two and remained unaltered in four patients. In the control group, GCS improved in seven, worsened in none and was unchanged in two patients. SPECT studies revealed reduction in asymmetry index in basal ganglia in four, frontal region in six, parietal in four and occipital region in five patients in mannitol group. In control group, asymmetry index was reduced in basal ganglia in one, frontal and parietal region in three each and occipital region in five patients. These differences between control and study group were not significant.
Mannitol does not seem to significantly change the regional cerebral blood flow (rCBF) in ICH patients as evaluated by SPECT study.
评估脑出血(ICH)患者静脉推注甘露醇后局部脑血流量(rCBF)的变化。
在一项基于医院的随机安慰剂对照研究中,21例经CT证实的格拉斯哥昏迷量表(GCS)评分为5分或更高的ICH患者接受了包括GCS和加拿大神经卒中(CNS)量表在内的临床评估。在20分钟内静脉注射100 ml 20%甘露醇或进行假输注前及输注后60分钟进行头颅单光子发射计算机断层扫描(SPECT)研究。对SPECT图像进行半定量分析,并计算基底节、额叶、顶叶和枕叶区域的不对称指数。
甘露醇组有12例患者,对照组有9例患者,两组在年龄、平均动脉血压、GCS评分和血肿大小方面匹配良好。甘露醇组仅1例患者死亡。使用甘露醇后,6例患者GCS评分改善,2例恶化,4例不变。对照组中,7例患者GCS评分改善,无恶化,2例不变。SPECT研究显示,甘露醇组4例患者基底节不对称指数降低,6例额叶、4例顶叶和5例枕叶降低。对照组中,1例基底节、3例额叶和顶叶以及5例枕叶不对称指数降低。对照组和研究组之间的这些差异无统计学意义。
通过SPECT研究评估,甘露醇似乎不会显著改变ICH患者的局部脑血流量(rCBF)。